Cargando…
A 41-year-old man with polyarthritis and severe autonomic neuropathy
Orthostasis due to autonomic neuropathy can cause severe debilitation and prove refractory to treatment. This report describes a case of severe sympathetic and parasympathetic autonomic dysfunction as a consequence of acetylcholine receptor antibodies and Sjogren’s syndrome. Symptomatic management,...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621382/ https://www.ncbi.nlm.nih.gov/pubmed/19209266 |
_version_ | 1782163403261870080 |
---|---|
author | Bourcier, Matthew E Vinik, Aaron I |
author_facet | Bourcier, Matthew E Vinik, Aaron I |
author_sort | Bourcier, Matthew E |
collection | PubMed |
description | Orthostasis due to autonomic neuropathy can cause severe debilitation and prove refractory to treatment. This report describes a case of severe sympathetic and parasympathetic autonomic dysfunction as a consequence of acetylcholine receptor antibodies and Sjogren’s syndrome. Symptomatic management, plasma fluid expanders, and IVIG therapy failed to offer a salutary response to the condition. Etanercept therapy provided improvement of the orthostasis and autonomic function measured as high and low frequency respiratory effects on heart rate variability as well as enhancement of skin blood flow using Laser Doppler. It would be of considerable interest to determine the effectiveness of etanercept in other autoimmune neuropathies. |
format | Text |
id | pubmed-2621382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26213822009-02-10 A 41-year-old man with polyarthritis and severe autonomic neuropathy Bourcier, Matthew E Vinik, Aaron I Ther Clin Risk Manag Case Report Orthostasis due to autonomic neuropathy can cause severe debilitation and prove refractory to treatment. This report describes a case of severe sympathetic and parasympathetic autonomic dysfunction as a consequence of acetylcholine receptor antibodies and Sjogren’s syndrome. Symptomatic management, plasma fluid expanders, and IVIG therapy failed to offer a salutary response to the condition. Etanercept therapy provided improvement of the orthostasis and autonomic function measured as high and low frequency respiratory effects on heart rate variability as well as enhancement of skin blood flow using Laser Doppler. It would be of considerable interest to determine the effectiveness of etanercept in other autoimmune neuropathies. Dove Medical Press 2008-08 2008-08 /pmc/articles/PMC2621382/ /pubmed/19209266 Text en © 2008 Dove Medical Press Limited. All rights reserved |
spellingShingle | Case Report Bourcier, Matthew E Vinik, Aaron I A 41-year-old man with polyarthritis and severe autonomic neuropathy |
title | A 41-year-old man with polyarthritis and severe autonomic neuropathy |
title_full | A 41-year-old man with polyarthritis and severe autonomic neuropathy |
title_fullStr | A 41-year-old man with polyarthritis and severe autonomic neuropathy |
title_full_unstemmed | A 41-year-old man with polyarthritis and severe autonomic neuropathy |
title_short | A 41-year-old man with polyarthritis and severe autonomic neuropathy |
title_sort | 41-year-old man with polyarthritis and severe autonomic neuropathy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621382/ https://www.ncbi.nlm.nih.gov/pubmed/19209266 |
work_keys_str_mv | AT bourciermatthewe a41yearoldmanwithpolyarthritisandsevereautonomicneuropathy AT vinikaaroni a41yearoldmanwithpolyarthritisandsevereautonomicneuropathy AT bourciermatthewe 41yearoldmanwithpolyarthritisandsevereautonomicneuropathy AT vinikaaroni 41yearoldmanwithpolyarthritisandsevereautonomicneuropathy |